Research and Markets: China Allergy Prescription Drug Sales Data 2006-2010

DUBLIN--()--Dublin - Research and Markets (http://www.researchandmarkets.com/research/03edc0a6/china_allergy_pres) has announced the addition of the "China Allergy Prescription Drug Sales Data 2006-2010" report to their offering.

This report systemically analyzes the Chinese allergy prescription drug market. All market estimates of allergy drug utilization in China are based on hospital drug prescription and drug purchasing data from extensive hospital coverage in 16 major cities and more than 300 hospitals. Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Xian, Shenyang, Harbin and Zhengzhou, covering significant percentages of all hospitals in these regions.

Market shares from all major manufacturers including multinational and Chinese pharmaceutical companies and key products are analyzed systemically. The comprehensive prescription data in China will present you with a clear picture of the competitive landscape of the Chinese allergy drug market and the market potential for your company's product(s) that are already marketed in China or if you are planning to bring your drugs to the China market.

This report is an indispensable reference for all levels of decision makers in pharmaceutical companies, medical device companies, healthcare investing companies and healthcare consulting companies. The unique allergy drug prescription and utilization data can provide valuable information for new product development, marketing and strategic planning functions for pharmaceutical companies. Compared to expensive customized drug sales reports in China, this multi-client report provides significant savings and great cost/benefit.

This Report Provides the Following Information:

- Annual national sales of allergy prescription drugs 2006-2010

- Annual national sales from each of the top manufacturers 2006-2010

- Annual national sales and market shares for each of the top drugs 2006-2010

- Annual national sales of the top drugs by each of the competing manufacturers 2006-2010

- Names, packages, prices and manufacturers of brand and generic drugs 2010

- Drugs on the Basic Medical Insurance List in 2010

Products Mentioned:

- Loratadine

- Cetirizine

- Desloratadine

- Mizolastine

- Epinastine

- Levocetirizine

- Ebastine

- Setastine

- Fexofenadine

- Allergen solvent

- Ketotifen Fumarate

- Triprolidine

- Promethazine

- Diphenhydramine

- Cyproheptadine

Companies Mentioned:

- Schering-Plough

- UCB

- Xian-Janssen

- Shandong Lunan

- Chongqing Huabang

- Chongqing Kailin

- Beijing Langyi

- Beijing Shuanglu

- Hangzhou Aoyi Baoling

- Shenzhen Haibin

- Eisai

- Hangzhou Huiyinbi

- Hainan Puli

- Shenzhen Xinlitai

- Jiangsu Lianhuan

- Zhejiang Wanma

- Nanjing Yihua

- San Jiu Yiyao

- Chengdu Minyi

- Yichang Changjiang

For more information visit http://www.researchandmarkets.com/research/03edc0a6/china_allergy_pres

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716
Sector: Pharmaceuticals